HRI is an internationally recognised medical research institute, with global collaborations.
It is a unique time to join HRI. The next few years have the potential to be transformative, with developments such as the $150 million Cardiovascular Disease Research Capacity Building Program backed by the NSW government in 2018, and HRI’s strong fundraising capabilities, which provide a reliable and independent source of long-term funding.
Our success comes down to our people. From our scientists and researchers, to our operations and fundraising staff – they all play key roles in ensuring HRI’s place as a world-leading medical research institute.
HRI is a centre of excellence in cardiovascular medical research affiliated with the Royal Prince Alfred Hospital and The University of Sydney, located over two locations in Eliza Street, Newtown and the Charles Perkins Centre (CPC) at The University of Sydney. For over 30 years, HRI has been one of Australia's leading research organisations working to detect, prevent and treat heart disease. Through our research, HRI has made significant findings that have changed the way we live with and treat cardiovascular disease.
The Thrombosis Group research program encompasses both basic discovery and translational research, and is broadly aimed at elucidating new cellular and molecular pathways that regulate inflammation and blood clotting (thrombosis) in the development of vascular disease. We are seeking a Postdoctoral Scientist to join our dynamic and highly successful collaborative research program. Find out more here.
Research Assistant in Bioinformatics – Cardiometabolic Disease Group (Indigenous Identified Position)
The Cardiometabolic Disease group aims to understand why cardiometabolic diseases (cardiovascular diseases driven by overweight, obesity, type 2 diabetes, metabolic syndrome) are more prevalent and devastating in Indigenous communities. We are seeking an RA of Indigenous background who will enable this program of research. Find out more here.
The successful applicant will be an integral part of a Clinical Research program that focuses on biology and new therapies for pulmonary hypertension. Your responsibilities will involve many techniques in cell and molecular biology, focusing on cells most involved in cardiovascular disease such as endothelial cells and vascular smooth muscle cells. You will especially be involved in performing immunohistochemistry, Western blot analysis, ELISA, immunofluorescence and microsurgery in small animal models of disease. Find out more here.